Results for "HDA Factbook"
Five Ways Healthcare Distributors Are Working to Mitigate Drug Shortages
Healthcare distributors’ operational capabilities, expertise in inventory management and broader network are critical to lessening the impact of shortages. The industry works continuously to anticipate potential disruptions and, if they do occur, act swiftly to help facilitate consistent and reliable access to prescription medicines.
Value Drug’s Modico Brothers Reflect on Nearly 50 Years in Healthcare Distribution
While many lead fulfilling, long-term careers in the healthcare distribution industry, the Modico brothers of HDA member Value Drug Company are part of a rare group of distribution experts who have done it for nearly 50 years.
The latest installments of HDA’s Faces of the Supply Chain series feature the brothers — Dave Modico, Warehouse Manager, and Sam Modico, Innovation Manager — who have been along for about half of Value Drug’s 90 years in business. Filmed at the company’s distribution center in Altoona, Pa., the brothers recount their decades in distribution and discuss the meaning behind their work.
Logistics Will Help Win the Battle Against COVID-19
Across the country, brave, frontline healthcare professionals are working around the clock as our nation grapples with the COVID-19 pandemic. These workers — the true heroes of the pandemic — are treating patients, maintaining vital healthcare operations and serving as emergency responders.
Technological Innovations Reshaping the Healthcare Supply Chain
Almost every industry is exploring the groundbreaking potential of new technologies involving automation, artificial intelligence (AI) and machine learning (ML), and the healthcare supply chain is no exception. While rapid innovation always brings some degree of uncertainty, the healthcare distribution industry has already found exciting opportunities for automation, AI and ML to assist employees, while also creating efficiencies that ultimately benefit providers and their patients.
Verification Network Update: Less than 60 Days Remain
Industry and service providers continue to work to implement the Drug Supply Chain Security Act’s (DSCSA) serialized saleable return milestone. With the end of FDA-granted enforcement discretion ending on November 27, 2020, and the industry simultaneously responding to COVID-19, it is all hands on deck to reach the compliance finish line.